Literature DB >> 17243117

Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function.

Garth L Nicolson1.   

Abstract

Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyceridemia, hyper-low-density lipoproteins, hypo-high-density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that-in combination with genetic susceptibility and abdominal obesity-are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17243117     DOI: 10.1002/jcb.21247

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  36 in total

Review 1.  Estrogen and mitochondria function in cardiorenal metabolic syndrome.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

2.  Corruption of coronary collateral growth in metabolic syndrome: Role of oxidative stress.

Authors:  Yuh Fen Pung; William M Chilian
Journal:  World J Cardiol       Date:  2010-12-26

3.  Effects of a high fat diet on liver mitochondria: increased ATP-sensitive K+ channel activity and reactive oxygen species generation.

Authors:  Ariel R Cardoso; João Victor Cabral-Costa; Alicia J Kowaltowski
Journal:  J Bioenerg Biomembr       Date:  2010-04-07       Impact factor: 2.945

Review 4.  Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies.

Authors:  Olesya Ilkun; Sihem Boudina
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

6.  A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.

Authors:  Ignazio Grattagliano; Catia V Diogo; Maria Mastrodonato; Ornella de Bari; Michele Persichella; David Q H Wang; Adriana Liquori; Domenico Ferri; Maria Rosaria Carratù; Paulo J Oliveira; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

Review 7.  Nutrition and reproduction: is there evidence to support a "Fertility Diet" to improve mitochondrial function?

Authors:  Katherine M Shaum; Alex J Polotsky
Journal:  Maturitas       Date:  2013-02-01       Impact factor: 4.342

8.  Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.

Authors:  Garth L Nicolson
Journal:  Integr Med (Encinitas)       Date:  2014-08

9.  Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Norman E Booth; Sarah Myhill; John McLaren-Howard
Journal:  Int J Clin Exp Med       Date:  2012-06-15

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.